Chronic phase of ETV6-ABL1 positive CML responds to imatinib

Norihiko Kawamata; Azadeh Dashti; Daning Lu; Becky Miller; H. Phillip Koeffler; Rhona Schreck; Stephen Moore; Seishi Ogawa

doi:10.1002/gcc.20593

Chronic phase of ETV6-ABL1 positive CML responds to imatinib

Norihiko Kawamata, Azadeh Dashti, Daning Lu, Becky Miller, H. Phillip Koeffler, Rhona Schreck, Stephen Moore, Seishi Ogawa

Research output: Contribution to journal › Letter › peer-review

19 Scopus citations

Original language	English (US)
Pages (from-to)	919-921
Number of pages	3
Journal	Genes Chromosomes and Cancer
Volume	47
Issue number	10
DOIs	https://doi.org/10.1002/gcc.20593
State	Published - Oct 1 2008
Externally published	Yes

ASJC Scopus subject areas

Genetics
Cancer Research

Access to Document

10.1002/gcc.20593

Cite this

@article{a1dfc65eab7a435ca585bceca00dac98,

title = "Chronic phase of ETV6-ABL1 positive CML responds to imatinib",

author = "Norihiko Kawamata and Azadeh Dashti and Daning Lu and Becky Miller and Koeffler, {H. Phillip} and Rhona Schreck and Stephen Moore and Seishi Ogawa",

year = "2008",

month = oct,

day = "1",

doi = "10.1002/gcc.20593",

language = "English (US)",

volume = "47",

pages = "919--921",

journal = "Genes Chromosomes and Cancer",

issn = "1045-2257",

publisher = "Wiley-Liss Inc.",

number = "10",

}

TY - JOUR

T1 - Chronic phase of ETV6-ABL1 positive CML responds to imatinib

AU - Kawamata, Norihiko

AU - Dashti, Azadeh

AU - Lu, Daning

AU - Miller, Becky

AU - Koeffler, H. Phillip

AU - Schreck, Rhona

AU - Moore, Stephen

AU - Ogawa, Seishi

PY - 2008/10/1

Y1 - 2008/10/1

UR - http://www.scopus.com/inward/record.url?scp=50249144024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50249144024&partnerID=8YFLogxK

U2 - 10.1002/gcc.20593

DO - 10.1002/gcc.20593

M3 - Letter

C2 - 18615681

AN - SCOPUS:50249144024

SN - 1045-2257

VL - 47

SP - 919

EP - 921

JO - Genes Chromosomes and Cancer

JF - Genes Chromosomes and Cancer

IS - 10

ER -

Chronic phase of ETV6-ABL1 positive CML responds to imatinib

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this